Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > BUSINESS
BUSINESS
- Fujirebio Files Blood-Based Diagnostic Test for Alzheimer’s in US
September 27, 2024
- Remitch OD Tablets Earns Indonesia Approval: Toray/Meiji Pharma
September 27, 2024
- RaQualia’s Acid Reducer Tegoprazan Approved in Malaysia
September 27, 2024
- Sawai Joins List of Atomoxetine Recalls after Establishing Test Model
September 27, 2024
- Nobelpharma Takes Nobelzin Patent Fight to IP High Court
September 27, 2024
- Santen Files Glaucoma Drug Sepetaprost in Japan
September 27, 2024
- Meiji’s COVID Jab Might Miss Initial Plan, but Awaits Real Game Next Year
September 26, 2024
- J&J to Offer Rybrevant for Free until NHI Price Listing
September 26, 2024
- Daiichi Sankyo’s TROP2 ADC Misses OS Goal in Breast Cancer Trial
September 25, 2024
- No Major Physical Damages Seen with Wholesalers after Noto Downpours
September 25, 2024
- Haihe’s MET Inhibitor Haiyitan Set for Launch on Oct. 11
September 25, 2024
- Kissei Takes Over Marizev Marketing Authorization from MSD Japan
September 25, 2024
- Daiichi Sankyo Releases JN.1-Tailored COVID Jab Daichirona
September 25, 2024
- Astellas’ Gastric Cancer Drug Vyloy Wins European Approval
September 25, 2024
- Otsuka Wraps Up Buyout of Jnana Therapeutics
September 25, 2024
- NHI-Market Price Gap on Narrowing Trend, but Results Remain Unpredictable
September 24, 2024
- Japan’s 1st CGP Assay for Blood Cancer Approved: Otsuka
September 24, 2024
- Tsumura to Cover Return Costs for China Staff after Shenzhen Stabbing
September 24, 2024
- 3 More Generic Firms Start Voluntary Recalls of Atomoxetine Products
September 20, 2024
- Xofluza Cuts Risk of Flu Transmission in Households: PIII Data
September 20, 2024
